Factors Influencing Men Undertaking Active Surveillance for the Management of Low-Risk Prostate Cancer

被引:75
|
作者
Davison, B. Joyce [1 ,2 ]
Oliffe, John L. [3 ]
Pickles, Tom [4 ]
Mroz, Lawrence
机构
[1] Univ British Columbia, Dept Urol, Vancouver, BC V5Z 1M9, Canada
[2] Vancouver Gen Hosp, Prostate Ctr, Vancouver, BC, Canada
[3] Univ British Columbia, Sch Nursing, Vancouver, BC V5Z 1M9, Canada
[4] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
基金
加拿大健康研究院;
关键词
QUALITY-OF-LIFE; SELECTIVE DELAYED INTERVENTION; RADICAL PROSTATECTOMY; EXPECTANT MANAGEMENT; CAPSURE; INFORMATION; CARCINOMA; PARTNERS; BRACHYTHERAPY; PREFERENCES;
D O I
10.1188/09.ONF.89-96
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose/Objectives: To identify and describe decision-making influences on men who decide to manage their low-risk prostate cancer with active surveillance. Research Approach: Qualitative, semistructured interview. Setting: The Prostate Centre at Vancouver General Hospital in Canada. Participants: 25 patients diagnosed with low-risk prostate cancer and on active Surveillance. Methodologic Approach: An interpretative, descriptive, qualitative design. Main Research Variables: Factors that influenced men's decisions to take up active surveillance. Findings: The specialists' description of the prostate cancer was the most influential factor on men choosing active surveillance. Patients did not consider their prostate cancer to be life threatening and, in general, were relieved that no treatment was required. Avoiding treatment-related suffering and physical dysfunction and side effects such as impotence and incontinence was cited as the major reason to delay treatment. Few men actively sought treatment or health-promotion information following their treatment decision. Female partners played a supportive role in the decision. The need for active treatment if the cancer progressed was acknowledged. Patients were hopeful that new treatments would be available when and if they needed them. Being older and having comorbidities did not preclude the desire for future active treatment. Patients carried on with their lives as usual and did not report having any major distress related to being on active surveillance. Conclusions: The study findings indicate that men are strongly influenced by the treating specialist in taking up active surveillance and planning future active treatments. As such, most men relied on their specialists' recommendation and did not perceive the need for any adjunct therapy or support until the cancer required active treatment. Interpretation: Oncology nurses should work collaboratively with specialists to ensure that men receive the information they need to make informed treatment decisions.
引用
收藏
页码:89 / 96
页数:8
相关论文
共 50 条
  • [21] Active Surveillance for Black Men with Low-Risk Prostate Cancer in the United States
    Al Awamlh, Bashir Al Hussein
    Hu, Jim C.
    Shoag, Jonathan E.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (26): : 2581 - 2582
  • [22] Factors Influencing Men's Choice of and Adherence to Active Surveillance for Low-risk Prostate Cancer: A Mixed-method Systematic Review
    Kinsella, Netty
    Stattin, Par
    Cahill, Declan
    Brown, Christian
    Bill-Axelson, Anna
    Bratt, Ola
    Carlsson, Sigrid
    Van Hemelrijck, Mieke
    EUROPEAN UROLOGY, 2018, 74 (03) : 261 - 280
  • [23] THE IMPACT OF SOCIO-DEMOGRAPHIC FACTORS ON ACTIVE SURVEILLANCE CHOICE IN MEN WITH LOW-RISK PROSTATE CANCER
    Kim, Brian
    Merchant, Madhur
    Slezak, Jeff
    Porter, Kimberly
    Gelfond, Joy
    Jacobsen, Steven J.
    Chien, Gary W.
    JOURNAL OF UROLOGY, 2014, 191 (04): : E57 - E58
  • [24] Active surveillance preferred for low-risk prostate cancer
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2015, 16 (08): : E384 - E384
  • [25] Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
    Augustin, Herbert
    Mayerhofer, Katrin
    Seles, Maximilian
    Pummer, Karl
    UROLOGIA INTERNATIONALIS, 2015, 95 (02) : 125 - 131
  • [26] Active Surveillance for Low-Risk Localized Prostate Cancer
    Large, Michael C.
    Eggener, Scott E.
    ONCOLOGY-NEW YORK, 2009, 23 (11): : 974 - 979
  • [27] Dutasteride and active surveillance of low-risk prostate cancer
    Fleshner, Neil E.
    LANCET, 2012, 379 (9826): : 1590 - 1590
  • [28] Active surveillance for low-risk prostate cancer: an update
    Lawrentschuk, Nathan
    Klotz, Laurence
    NATURE REVIEWS UROLOGY, 2011, 8 (06) : 312 - 320
  • [29] Active surveillance for low-risk prostate cancer: an update
    Nathan Lawrentschuk
    Laurence Klotz
    Nature Reviews Urology, 2011, 8 : 312 - 320
  • [30] Active Surveillance for Low-Risk Prostate Cancer Reply
    Lellig, Katja
    Buchner, Alexander
    Stief, Christian
    UROLOGE, 2015, 54 (06): : 870 - 870